Randy Milby - 20 May 2022 Form 4 Insider Report for Hillstream BioPharma Inc. (THAR)

Role
Chief Executive Officer, Director
Signature
/s/ Randy Milby
Issuer symbol
THAR
Transactions as of
20 May 2022
Net transactions value
+$918
Form type
4
Filing time
23 May 2022, 16:15:27 UTC
Previous filing
19 May 2022
Next filing
25 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction THAR Common Stock Purchase $445 +500 +0.02% $0.8900 2,936,039 20 May 2022 Direct
transaction THAR Common Stock Purchase $473 +500 +0.02% $0.9465 2,936,539 20 May 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.